Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use

Journal of Medical Virology

Volumn 82, Issue 9, 2010, Pages 1606-1611

  Malm, Kerstin ^a   Kjerstadius, Torbjörn ^b   Andersson, Sören ^c  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Assay evaluation; HTLV 1 2; Sensitivity; Specificity

Indexed keywords

VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL EVALUATION; CLINICAL LABORATORY; CONTROLLED STUDY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOASSAY; MAJOR CLINICAL STUDY; RHTLV I/II IMMUNOASSAY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY; VIRUS INFECTION;

FALSE POSITIVE REACTIONS; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; IMMUNOASSAY; LUMINESCENT MEASUREMENTS; MASS SCREENING; SENSITIVITY AND SPECIFICITY;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 77956591317     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21867     Document Type: Article

References (18)

1. Andersson S, Krook A, Käll K, Julander I, Thorstensson R, Biberfeld G. 1995. HTLV infections among Swedish intravenous drug users in 1992. Scand J Infect Dis 27:547-550.
2. Andersson S, Dias F, Mendez PJ, Rodrigues P, Biberfeld G. 1997. HTLV-I and -II infections in a nationwide survey of pregnant women in Guinea-Bissau, West Africa. J Accuir Immune Defic Syndr Hum Retrovirol 15:320-322.
3. Andersson S, Thorstensson R, Godoy Ramirez K, Krook A, von Sydow M, Dias F, Biberfeld G. 1999. Comparative evaluation of 14 immunoassays for detection of antibodies to the human Tlymphotropic virus types I and II using panels of sera from Sweden and West Africa. Transfusion 39:845-851.
4. Andersson S, Gessain A, Taylor GP. 2001. Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus types I and II. Virus Res 78:101-106.
5. Berini CA, Pascuccio MS, Bautista CT, Gendler SA, Eirin ME, Rodriguez C, Pando MA, Biglione MM. 2008. Comparision of four commercial screening assays for the diagnosis of human T-cell Lymphotropic virus types 1 and 2. J Virol Methods 147:322-327.
6. Calattini S, Chevalier SA, Duprez R, Bassot S, Froment A, Mahieux R, Gessain A. 2005. Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retorvirology 2:30.
7. Chang CS, Wu YW, Pan YC, Chen ZY, Wang CS. 2002. Feasibility of human T-lymphotropic virus type I screening using pooled sera. J Formos Med Assoc 101:775-778.
8. Hall WW, Ishak R, Zhu SW, Novoa P, Eiraku N, Takahashi H, da Costa Ferreira M, Azevedo V, Ishak MO, da Costa Ferreira O, Monken C, Kurata T. 1996. Human T lymphotropic virus type II (HTLV-II): Epidemiology, molecular properties, and clinical features of infection. J Acquir Immune Defic Syndr Hum Retrovirol 13:S204-S214.
9. Hendriks AH, Kortlandt W, Verweij WM. 2000. Standardized comparison of processing capacity and efficiency of five new-generation immunoassay analyzers. Clin Chem 46:105-111.
10. Kim S, Kim JH, Yoon S, Park YH, Kim HS. 2008. Clinical performance evaluation of four automated chemiluminescence immunoassays for Hepatitis C virus antibody detection. J Clin Microbiol 46:3919-3923.
11. Malm K, von Sydow M, Andersson S. 2009. Performance of three automated fourth generations combined HIV antigen/antibody assays in large scale screening of blood donors and clinical samples. Transfus Med 19:78-88.
12. Marangoni A, Moroni A, Accardo S, Cevenini R. 2009. Laboratory diagnosis of syphilis with automated immunoassays. J Clin Lab Anal 23:1-6.
13. Norrgren H, Andersson S, Nauclér A, Dias F, Johansson I, Biberfeld G. 1995. HIV-1, HIV-2, HTLVI/II and Treponema pallidum infections: Incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau. J Accuir Immune Defic Syndr Hum Retrovirol 9:422-428.
14. Qiu X, Hodges S, Lukaszewska T, Hino S, Arai H, Yamaguchi J, Swanson P, Schochetman G, Devare SG. 2008. Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies. J Med Virol 80:484-493.
15. Switzer WM, Qari SH, Wolfe ND, Burke DS, Folks TM, Heneine W. 2006. Ancient origin and molecular features of the novel human T-lymphotropic virus type 3 revealed by complete genome analysis. J Virol 80:7427-7438.
16. Thorstensson R, Albert J, Andersson S. 2002. Strategies for diagnosis of HTLV-I and -II. Transfusion 42:780-791.
17. Verdonck K, González E, Van Dooren S, Vandamme A-M, Vanham G, Gotuzzo E. 2007. Human T-lymphotropic virus 1: Recent knowledge about an ancient infection. Lancet Infect Dis 7:266-281.
18. Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, Torimiro JN, Prosser AT, Lebreton M, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Switzer WM. 2005. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci USA 102: 7994-7999.